drugset / Trial / NCT02490774

To Investigate the Pharmacological Effects, Drug Blood Levels and Safety of an Intrauterine System Releasing the Study Drug BAY1007626 in Comparison to Mirena and Jaydess in Healthy Young Women Treated for 90 Days to Determine the Drug Dose for Further Development

NCT02490774

Phase 2 Terminated 174 enrolled Bayer
RandomizedParallel-groupDouble-blindTreatment

Summary

Investigation of pharmacological effects, drug blood levels and safety of an intrauterine system releasing the study drug BAY1007626 in comparison to Mirena and Jaydess in healthy young women treated for 90 days to determine the drug dose for further development

Timeline

Start
2015-06-22
Primary completion
2016-05-26
Completion
2016-07-22

Drugs

EvaluationDrugModalityDoseRoute
Subject BAY1007626 Unknown Other
Comparator Levonorgestrel Small molecule 12 ug Other
Comparator Levonorgestrel Small molecule 20 ug Other

Indications

No indication recorded.